Mehul U. Mehta

422 total citations
13 papers, 293 citations indexed

About

Mehul U. Mehta is a scholar working on Pediatrics, Perinatology and Child Health, Pharmaceutical Science and Analytical Chemistry. According to data from OpenAlex, Mehul U. Mehta has authored 13 papers receiving a total of 293 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pediatrics, Perinatology and Child Health, 4 papers in Pharmaceutical Science and 3 papers in Analytical Chemistry. Recurrent topics in Mehul U. Mehta's work include Pharmaceutical studies and practices (6 papers), Drug Solubulity and Delivery Systems (4 papers) and Analytical Methods in Pharmaceuticals (3 papers). Mehul U. Mehta is often cited by papers focused on Pharmaceutical studies and practices (6 papers), Drug Solubulity and Delivery Systems (4 papers) and Analytical Methods in Pharmaceuticals (3 papers). Mehul U. Mehta collaborates with scholars based in United States, Sweden and Netherlands. Mehul U. Mehta's co-authors include Ramana Uppoor, Yaning Wang, James E. Polli, J. Robert Powell, Lawrence X. Yu, Nam Atiqur Rahman, D.W. Groot, Venkatesh Atul Bhattaram, John Duan and Vinod P. Shah and has published in prestigious journals such as Journal of Pharmaceutical Sciences, Clinical Pharmacology & Therapeutics and Molecular Pharmaceutics.

In The Last Decade

Mehul U. Mehta

12 papers receiving 286 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mehul U. Mehta United States 11 63 54 50 46 40 13 293
Kimberly Raines United States 9 147 2.3× 69 1.3× 41 0.8× 45 1.0× 29 0.7× 13 256
Shinichi Kijima Japan 6 64 1.0× 51 0.9× 35 0.7× 46 1.0× 229 5.7× 10 399
Jan Welink Netherlands 11 141 2.2× 76 1.4× 99 2.0× 42 0.9× 39 1.0× 25 459
Henrike Potthast Germany 10 241 3.8× 51 0.9× 55 1.1× 39 0.8× 16 0.4× 20 421
Fairouz Makhlouf United States 6 53 0.8× 48 0.9× 120 2.4× 188 4.1× 40 1.0× 8 378
B Booth United States 5 41 0.7× 88 1.6× 80 1.6× 79 1.7× 171 4.3× 17 535
Paulo Paixão Portugal 14 160 2.5× 143 2.6× 61 1.2× 54 1.2× 103 2.6× 34 608
Donato Teutonico France 12 99 1.6× 125 2.3× 106 2.1× 50 1.1× 185 4.6× 22 674
Serge Guzy United States 9 31 0.5× 80 1.5× 17 0.3× 56 1.2× 35 0.9× 27 305
Patricia Zane United States 11 112 1.8× 104 1.9× 49 1.0× 15 0.3× 18 0.5× 15 474

Countries citing papers authored by Mehul U. Mehta

Since Specialization
Citations

This map shows the geographic impact of Mehul U. Mehta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mehul U. Mehta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mehul U. Mehta more than expected).

Fields of papers citing papers by Mehul U. Mehta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mehul U. Mehta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mehul U. Mehta. The network helps show where Mehul U. Mehta may publish in the future.

Co-authorship network of co-authors of Mehul U. Mehta

This figure shows the co-authorship network connecting the top 25 collaborators of Mehul U. Mehta. A scholar is included among the top collaborators of Mehul U. Mehta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mehul U. Mehta. Mehul U. Mehta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Nallani, Srikanth C., Zhihua Li, Jeffry Florian, et al.. (2024). FDA Approval Summary: Nalmefene Nasal Spray for the Emergency Treatment of Known or Suspected Opioid Overdose. Clinical Pharmacology & Therapeutics. 117(3). 620–626.
2.
Shu, Yan, Bertil Abrahamsson, Rodrigo Cristofoletti, et al.. (2021). Biowaiver Monographs for Immediate Release Solid Oral Dosage Forms: Metformin Hydrochloride. Journal of Pharmaceutical Sciences. 110(4). 1513–1526. 18 indexed citations
3.
Abrahamsson, Bertil, Rodrigo Cristofoletti, D.W. Groot, et al.. (2020). Biowaiver Monographs for Immediate Release Solid Oral Dosage Forms: Cephalexin Monohydrate. Journal of Pharmaceutical Sciences. 109(6). 1846–1862. 11 indexed citations
4.
Abrahamsson, Bertil, Rodrigo Cristofoletti, Peter Langguth, et al.. (2018). Biowaiver Monographs for Immediate Release Solid Oral Dosage Forms: Proguanil Hydrochloride. Journal of Pharmaceutical Sciences. 107(7). 1761–1772. 6 indexed citations
5.
Li, Liang, Yaning Wang, Ramana Uppoor, et al.. (2017). Exposure–response analyses of blood pressure and heart rate changes for methylphenidate in healthy adults. Journal of Pharmacokinetics and Pharmacodynamics. 44(3). 245–262. 11 indexed citations
6.
Mehta, Mehul U., Ramana Uppoor, Dale P. Conner, et al.. (2017). Impact of the US FDA “Biopharmaceutics Classification System” (BCS) Guidance on Global Drug Development. Molecular Pharmaceutics. 14(12). 4334–4338. 25 indexed citations
7.
Souza, Jacqueline de, Neila Márcia Silva-Barcellos, Bertil Abrahamsson, et al.. (2017). Biowaiver Monographs for Immediate-Release Solid Oral Dosage Forms: Folic Acid. Journal of Pharmaceutical Sciences. 106(12). 3421–3430. 24 indexed citations
8.
Goodarzi, Navid, Bertil Abrahamsson, Rodrigo Cristofoletti, et al.. (2016). Biowaiver Monographs for Immediate Release Solid Oral Dosage Forms: Ribavirin. Journal of Pharmaceutical Sciences. 105(4). 1362–1369. 18 indexed citations
9.
Nair, Anil K., Om Anand, Dale P. Conner, et al.. (2012). Statistics on BCS Classification of Generic Drug Products Approved Between 2000 and 2011 in the USA. The AAPS Journal. 14(4). 664–666. 17 indexed citations
10.
Bhattaram, Venkatesh Atul, Brian Booth, B. Nhi Beasley, et al.. (2005). Impact of pharmacometrics on drug approval and labeling decisions: A survey of 42 new drug applications. The AAPS Journal. 7(3). E503–E512. 95 indexed citations
11.
Yu, Lawrence X., Arthur B. Straughn, Patrick J. Faustino, et al.. (2004). The Effect of Food on the Relative Bioavailability of Rapidly Dissolving Immediate-Release Solid Oral Products Containing Highly Soluble Drugs. Molecular Pharmaceutics. 1(5). 357–362. 30 indexed citations
12.
Gallo, James M., et al.. (1992). Pharmacokinetic Evaluation of Drug Interactions with Anti-HIV Drugs, II: Effect of 2′,3′-Dideoxyinosine (ddI) on Zidovudine Kinetics in Monkeys. AIDS Research and Human Retroviruses. 8(2). 277–283. 12 indexed citations
13.
Mehta, Mehul U., Raman Venkataramanan, Gilbert J. Burckart, et al.. (1986). Antipyrine kinetics in liver disease and liver transplantation. Clinical Pharmacology & Therapeutics. 39(4). 372–377. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026